Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis
- DOI
- 10.3389/fcell.2022.845457
- Published
- 2022-03-31
- Container
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fcell.2022.845457,
title = {Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis},
author = {Debasis Sahu and Subasa Chandra Bishwal and Md. Zubbair Malik and Sukanya Sahu and Sandeep Rai Kaushik and Shikha Sharma and Ekta Saini and Rakesh Arya and Archana Rastogi and Sandeep Sharma and Shanta Sen and R. K. Brojen Singh and Chuan-Ju Liu and Ranjan Kumar Nanda and Amulya Kumar Panda},
year = {2022},
journal = {Frontiers in Cell and Developmental Biology},
doi = {10.3389/fcell.2022.845457},
url = {https://doi.org/10.3389/fcell.2022.845457}
}RIS
TY - JOUR TI - Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis AU - Debasis Sahu AU - Subasa Chandra Bishwal AU - Md. Zubbair Malik AU - Sukanya Sahu AU - Sandeep Rai Kaushik AU - Shikha Sharma AU - Ekta Saini AU - Rakesh Arya AU - Archana Rastogi AU - Sandeep Sharma AU - Shanta Sen AU - R. K. Brojen Singh AU - Chuan-Ju Liu AU - Ranjan Kumar Nanda AU - Amulya Kumar Panda PY - 2022 JO - Frontiers in Cell and Developmental Biology DO - 10.3389/fcell.2022.845457 UR - https://doi.org/10.3389/fcell.2022.845457 ER -
APA
Sahu, D., Bishwal, S. C., Malik, M. Z., Sahu, S., Kaushik, S. R., Sharma, S., Saini, E., Arya, R., Rastogi, A., Sharma, S., Sen, S., Singh, R. K. B., Liu, C., Nanda, R. K., & Panda, A. K. (2022). Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis. Frontiers in Cell and Developmental Biology. https://doi.org/10.3389/fcell.2022.845457
Source records
- crossref · retrieved 2026-09-26T20:30:09.239Z